The Magazine for Sleep Professionals
Tuesday, March 17, 2026
Dental Sleep Medicine | Sleep Disorders | Testing Modalities & Diagnostics | Patient Health | Pharmaceuticals | Research/Studies
This rising demand collides with real operational constraints, such as credentialed technologists and physician shortages, aging equipment, getting out in front of evolving billing codes in 2026, and the modifications needed for the type of HST devices utilized, fragmented software, EMR integration requirements, capital constraints, and pressure to expand home‑based […]
Panthera Dental is proud to announce Dr. Chidsanu Changsiripun (PI), D.D.S., M.Sc., Ph.D., from Chulalongkorn University, Thailand, as the recipient of the 2025 Panthera Sleep Research Grant. Dr. Changsiripun’s research proposal, Deep Learning-Assisted vs. Conventional Subjective Titration in MAD Therapy for OSA, was selected through a rigorous anonymous peer-review process […]
UCLA Research Brief A new study led by UCLA investigators shows that Verbal Reaction Time (VRT), the amount of time it takes a person to respond verbally, can be a marker of sleepiness in older adults. The study, which measured participants’ voice data through standardized cognitive assessments, show how VRT […]
Nexalin Technology, Inc. announced continued advancement toward its planned pivotal clinical trial evaluating HALO™ Clarity for the treatment of moderate to severe insomnia, designed to support Nexalin’s planned de novo submission to the U.S. Food and Drug Administration. The study is being conducted in collaboration with Lindus Health, a full-service clinical […]
REMSleep Holdings, Inc., developer of the FDA-cleared DeltaWave(TM) nasal pillow system, announced the full commercial launch of the DeltaWave product portfolio across all U.S. distribution channels, including durable medical equipment (DME) companies and institutional sales. With expanded FDA 510(k) clearance secured on January 15 and Medicare PDAC coding approved for every product […]
After more than two decades in the global sleep medicine industry, Julia Sarmiento, former Director of Sales of the Americas for SOMNOmedics US, has launched and rapidly expanded Techno Xperts, a dedicated distribution platform serving Latin America. The company was established to increase access to advanced sleep diagnostics technologies while […]
Jamison Spencer, DDS, MS, will serve as a contributing author for Sleepedu. His responsibilities will be primarily to author dental-sleep-related courses. Dr. Spencer has a passion for bringing practicing sleep dentists and physicians together to foster understanding and mutual respect between the two groups. His courses will discuss those relationships […]
Harmony Biosciences announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental new drug application (sNDA) for WAKIX® (pitolisant) tablets for the treatment of cataplexy in pediatric patients 6 years of age and older with narcolepsy. WAKIX is now the first-and-only FDA-approved non-scheduled treatment for pediatric and adult […]
Alkermes plc and Avadel Pharmaceuticals plc, announced Alkermes’ completion of its acquisition of Avadel, a commercial-stage biopharmaceutical company. The acquisition adds Avadel’s FDA-approved product, LUMRYZ®, to Alkermes’ commercial portfolio, and provides Alkermes with a commercial organization experienced in this disease state. This strategic move accelerates Alkermes’ entry into the sleep […]
Sunrise Group, a pioneer in medical device innovation and sleep care, today announced a new peer-reviewed study in Nature Communications Medicine. Sunrise developed the only home sleep test with respiratory effort measurement that has been validated against esophageal pressure, the reference standard. The study reveals that REMOV, the Sunrise-specific marker […]
